
Dash Pharma
达石药业
Dash Pharma
Biotech/Healthcare
Dashi Pharma is an innovative antibody drug developer focused on novel biotech therapies, primarily antibody drugs for oncology. Two drug molecules have entered preclinical development.
Latest round: Series B (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-01-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.